InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Howard Elizabeth. Officer active across 1 company, notably Arbutus Biopharma Corp. In total, 1 reports have been published. History available since 1 February 2023. The latest transaction was disclosed on 1 February 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration